Small activating RNAs (saRNAs) are short double-stranded RNAs used in RNA activation (RNAa) studies to increase expression of selected genes through promoter- or transcription-associated mechanisms. Unlike conventional RNA interference, which is generally designed to reduce target expression, RNAa projects require promoter-aware target selection, strand design, appropriate controls, and careful evaluation of whether an observed expression change is sequence dependent.
Our custom small activating RNA synthesis service supports sequence design, duplex production, chemical modification, purification, analytical verification, and screening-set preparation for research use. The workflow can be coordinated with custom dsRNA synthesis, DNA/RNA modification, and oligo analysis and purification when the project requires broader RNA chemistry support.
Fig 1. Proposed model of small activating RNA mechanism. (Kwok et al., 2019)
Promoter Target Selection: RNAa activity depends strongly on target location and sequence context around promoter or transcription-associated regions. Multiple candidate sites are often needed because sequence complementarity alone does not guarantee activation.
Guide-Strand Selection: As with other short RNA duplexes, strand loading and thermodynamic asymmetry can influence which strand participates in Argonaute-associated activity. Duplex architecture should support the intended guide strand while minimizing unintended complementary-strand effects.
Off-Target Homology: Short duplex RNAs can interact with partially related transcripts or genomic-associated RNAs. Candidate screening should consider seed-region similarity, repetitive elements, and unintended sequence matches.
Chemical Modification Balance: Modifications can improve stability or handling but may also alter Argonaute loading, nuclear trafficking, or RNAa activity. Modification pattern should be conservative and position-aware unless supported by prior project data.
Duplex Purity and Annealing: Incorrect strand ratio, truncated RNA, or incomplete annealing can introduce variable active material. Both strands should be purified and characterized before controlled duplex formation.
Functional Confirmation: RNAa readouts are influenced by promoter state, basal expression, cell context, delivery, and time point. Proper non-targeting controls, mock controls, and independent candidate sequences help separate true sequence-dependent activation from assay noise.
Our saRNA workflow is designed for research teams that need chemically defined short RNA duplexes and a practical path from target-gene selection to candidate screening. Customers may provide exact sequences or request design support around a defined gene and promoter region.
This page refers to small activating RNA. If your project involves replicating long IVT RNA, see our custom self-amplifying RNA synthesis service; the two platforms share the abbreviation saRNA but are technically distinct.
RNAa projects typically benefit from evaluating several independent sequence and assay variables in parallel rather than relying on a single predicted duplex.
| Design Factor | Why It Matters | Practical Review | Risk if Ignored | Project Action |
| Promoter/TSS Context | RNAa activity is linked to promoter-associated target context rather than conventional mRNA knockdown sites | Map candidate windows around annotated transcription start and promoter-associated regions | Candidate may not engage the regulatory context needed for activation | Design several sites spanning the target region |
| Sequence Composition | Extreme GC content, long repeats, or self-complementarity can affect synthesis, duplex behavior, and specificity | Review GC balance, homopolymers, predicted structure, and repeat content | Poor synthesis, aggregation, unstable duplex, or nonspecific behavior | Filter or reprioritize problematic sequences |
| Guide-Strand Bias | Argonaute loading may favor one strand depending on terminal stability and duplex architecture | Compare end stability and intended guide orientation | Passenger-strand loading may complicate interpretation | Tune duplex ends and preserve intended guide architecture |
| Off-Target Similarity | Short RNA sequences can recognize partially related sites | Check seed and full-length similarity against relevant transcript/genomic contexts | Expression changes may not be target-specific | Select lower-risk candidates and include independent sequences |
| Chemical Modification | Stability-enhancing chemistry can also alter protein interactions | Review each modification by position and purpose | Over-modification may reduce RNAa activity or confound mechanism | Use conservative patterns and compare with unmodified control when needed |
| Controls | RNAa phenotypes are sensitive to cell state and delivery | Plan non-targeting, mock, and multiple independent saRNA candidates | A single readout may be misattributed to sequence-specific activation | Build controls into synthesis and screening plan |
Project format can be scaled from a single designed duplex to a screening panel with labels, modifications, and matched controls.
| Project Format | Recommended When | Typical Components | Purification / QC | Primary Deliverable |
| Single saRNA Duplex | Customer already has a defined sequence | Sense strand, antisense strand, duplex annealing | HPLC or PAGE as appropriate; mass/purity check | Research-ready duplex with strand information |
| Candidate Panel | Target site is uncertain or multiple promoter regions need testing | Several duplexes plus non-targeting control | Normalized purification and QC across candidates | Panel formatted for comparative screening |
| Modified saRNA | Stability or handling needs require chemistry changes | Selected 2′, backbone, or terminal modifications | Method adjusted for modification chemistry | Modified duplex and analytical data |
| Fluorescent saRNA | Uptake or localization must be monitored | Fluorophore-labeled strand, linker, matched control | Label-aware HPLC/PAGE plus mass verification | Labeled duplex suitable for tracking studies |
| Design + Synthesis | Only gene target is defined at project start | Target-site review, sequence candidates, controls, synthesis | Candidate-specific QC and documented sequence set | Designed saRNA panel for research screening |
The workflow separates target-site design from chemistry execution so biological uncertainty can be addressed with multiple well-controlled candidates.
Define the target gene, species, transcript annotation, promoter/TSS context, desired expression readout, and experimental model.
Generate or review several saRNA candidate sites, screen composition and sequence similarity, and define the intended guide orientation and controls.
Set strand length, overhangs, terminal groups, labels, and any chemical modifications. Modification is limited to positions compatible with the project objective.
Synthesize each RNA strand, purify using the selected method, and perform identity/purity checks appropriate to the strand chemistry.
Anneal sense and antisense strands at defined stoichiometry, normalize concentration, and prepare single candidates or screening panels in the requested format.
Provide sequence and analytical documentation and support follow-up candidate refinement based on expression, delivery, or localization results generated by the research team.
Small activating RNA projects are most informative when sequence design, chemical synthesis, controls, and follow-up screening are planned together.
saRNA is primarily a tool for studying transcriptional activation and promoter-associated gene regulation. The following applications focus on research and mechanism development.
Send the target gene, species, promoter or transcript annotation, any existing candidate sequences, desired chemical modifications, and planned assay. We can prepare a single duplex or a multi-candidate screening set with purification, analytical verification, and matched controls. Related services include custom dsRNA synthesis, RNA modification, and oligo analysis and purification. Contact us to discuss your small activating RNA project.
Small activating RNA is a short RNA duplex used in RNA activation studies to increase expression of selected genes through promoter- or transcription-associated mechanisms. siRNA is generally designed to reduce target RNA expression.
No. Small activating RNA is a short regulatory duplex used for RNA activation, whereas self-amplifying RNA is a much longer IVT RNA that encodes replication machinery and a payload. The shared abbreviation saRNA can cause confusion.
Candidate sites are reviewed in the context of the target promoter and transcription start region, along with GC content, repeats, self-complementarity, extended homology, and potential off-target similarity. Multiple candidates are usually preferable.
Yes, selected ribose, backbone, terminal, or label modifications can be considered. Modification placement should be conservative because excessive or poorly positioned chemistry may change Argonaute loading or RNAa activity.
Useful controls include a non-targeting duplex, mock treatment, and multiple independent saRNA sequences for the same gene. A sequence-dependent expression change is more convincing when it is reproduced by more than one candidate.
Loading ......
